Higher Dosage of ADHD Medications Linked to Psychosis Risk
Higher doses of ADHD medications including Adderall and Vyvanse may increase the risk of psychosis, a new study has found.
Drug Store News19d
Hikma intros clindamycin in 5% dextrose injection
Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...
Hikma Pharmaceuticals falls Friday, underperforms market
Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...
Mediafeed on MSN5mon
Cialis 20 mg: What You Need to Know Before Starting It
You might have seen Cialis® — the erectile dysfunction (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, ...
Drug Store News10d
Hikma completes Xellia acquisition
Hikma has completed its acquisition of Xellia Pharmaceuticals’ U.S. finished dosage form business and related assets following clearance under applicable U.S. antitrust laws. The acquisition ...
Mackolik22d
Shabab Al Sahel vs Al Hikma, 20.09.2024
Maç detayı sayfasında Premier Lig kapsamında oynanan Al Sahel – Al Hikma karşılaşmasına ait tarih, saat, stat, stat kapasitesi, maç haftası, takımların son beş maçlarında aldıkları sonuçlar, canlı ...
Mackolik3y
Racing vs Al Hikma, 20.12.2009
Maç detayı sayfasında Premier Lig kapsamında oynanan Yeni Racing – Al Hikma karşılaşmasına ait tarih, saat, stat, stat kapasitesi, maç haftası, takımların son beş maçlarında aldıkları sonuçlar, canlı ...
in.investing.com on MSN1mon
Hikma Pharmaceuticals shares surge on upbeat guidance
Investing.com -- Shares of Hikma Pharmaceuticals (LON:HIK) jumped on Thursday after the company raised its full-year guidance ...
Seeking Alpha5d
HKMPY Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics ...
MarketWatch18d
Hikma Pharmaceuticals rises Wednesday, outperforms market
Hikma Pharmaceuticals PLC HIK shares inched up 0.82% to £19.77 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.35% ...
Reuters17d
Hikma Pharmaceuticals PLC
Worldcategory Dechra, Hikma, M&S and Diploma set to join FTSE 100 August 23, 2023 Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider ...
Seeking Alpha7d
HKMPF Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics ...